Danish eSports team wins ELEAGUE Major

Astralis in come-from-behind triumph in Atlanta

The Danish eSports team Astralis cemented its position as one of the top Counter-Strike teams in the world by coming out on top at the ELEAGUE Major in Atlanta on Sunday.

The Danes found themselves trailing Polish outfit Virtus.pro in a best of three map final showdown, but stormed back to win the final two maps and the championship. The final score was 12-16, 16-14 and 16-14.

The Danes won a check for nearly 3.5 million kroner and the victory means they are currently ranked number one in the world.

READ MORE: FC Copenhagen and Nordisk Film in massive eSports push

Nearly North
Another Danish team, North – which recently launched in co-operation with FC Copenhagen football club – finished in the 5-8 placements.

Relive the final seconds of the championship and see the winning shot in the video below.





  • How internationals can benefit from joining trade unions

    How internationals can benefit from joining trade unions

    Being part of a trade union is a long-established norm for Danes. But many internationals do not join unions – instead enduring workers’ rights violations. Find out how joining a union could benefit you, and how to go about it.

  • Internationals in Denmark rarely join a trade union

    Internationals in Denmark rarely join a trade union

    Internationals are overrepresented in the lowest-paid fields of agriculture, transport, cleaning, hotels and restaurants, and construction – industries that classically lack collective agreements. A new analysis from the Workers’ Union’s Business Council suggests that internationals rarely join trade unions – but if they did, it would generate better industry standards.

  • Novo Nordisk overtakes LEGO as the most desirable future workplace amongst university students

    Novo Nordisk overtakes LEGO as the most desirable future workplace amongst university students

    The numbers are especially striking amongst the 3,477 business and economics students polled, of whom 31 percent elected Novo Nordisk as their favorite, compared with 20 percent last year.